STAT3 and Burkitt lymphoma: Since STAT3, MYC, and EBNA1 are each essential for survival and proliferation of EBV-transformed and cancer cells, we tested the effects of the three inhibitors on cell viability and apoptosis in EBV+ HH514–16 BL cells.